medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2011, Número 599

<< Anterior Siguiente >>

Rev Med Cos Cen 2011; 68 (599)


Una actualización en aborto recurrente

Murillo MC, Murillo RO

Idioma: Español
Referencias bibliográficas: 44
Paginas: 423-433
Archivo PDF: 500.58 Kb.


RESUMEN

El aborto recurrente es sorprendentemente frecuente con aproximadamente un 15% de todos los embarazos clínicos reconocidos resultando en pérdida del embarazo. El aborto recurrente ha sido definido de manera inconsistente. Este se define como 3 ó más abortos espontáneos consecutivos antes de las 20 semanas de gestación y afecta del 1 al 2% de las mujeres Sin embargo, existe gran dificultad para evaluar correctamente una determinada terapia, ya que el 50% de las parejas no tratadas conciben un hijo normal en el siguiente embarazo. Por lo cual, el clínico continúa omitiendo su metodología diagnóstica impidiendo con ello un correcto manejo. El presente artículo tiene como objeto analizar el problema desde el punto de vista clínico y terapéutico investigando las etiologías actuales involucradas en esta patología. En detalle nos da las recomendaciones para detectar tempranamente la enfermedad y enfatiza que su manejo debe ser basado en evidencias, evitando tratamientos experimentales o sin sustento científico. Con el avance en la tecnología se ha visto un cambio en la incidencia de las diferentes etiologías ubicando el aborto recurrente dentro de las principales causas del aborto.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Reprod Update. 2000; 6:614-620.

  2. Bubanovic I .1 alpha, 25-dihidroxy-vitamin-D3 as new immunotherapy in treatment of recurrent spontaneous abortion. Med Hypotheses 2004; 63:250-253.

  3. Chaouat G, Menu E, De Smedt D, et al; TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/ early abortion: reexamining the TH1/Th2 paradigm. Int Arch Allergy Immunol 2004; 134: 93.

  4. Coulam CB, Clark DA, Beer AE, Kutteh WH, Silver R, Kwak J, Stephenson M. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Clinical Guidelines Recommendation Committee for Diagnosis and Treatment of Recurrent Spontaneous Abortion. Am J Reprod Immunol 1997; 38:57-74.

  5. Cowchock FS, Reece EA, Balban D, et al: Repeated fetal looses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166:1318.

  6. Creus M, Ballast J, Fabregues F, Martorell J, Boada M, Penarrubia J. Barri PN, Vanrell JA. Parental human leukocyte antigens and implantation failure after in-vitro fertilization. Hum Reprod 1998; 13:39-43.

  7. Culić V, Konjevoda P, Mise K, Kardum G, Matijević T, Pavelić J., Genitourinary diseases prior spontaneous abortion as a risk factor for recurrent pregnancy loss., Rev. Coll Antropol. 2009; 33(1):187-192.

  8. Daya S. Recurrent miscarriage. Infertility and Reproductive Medicine Clinics of North America, October 1996; 7(4).

  9. Fabres C, Arriagada P, Fernández C, Mackenna A, et al. Surgycal treatment and follow up of woman and intermenstrual due to cesarean sections scar defect. Unit of Reproductive Medicine. J Minim Invasive Gynecol 2005; 12(3):25-28.

  10. Fedorcsak P, Dale PO, Storeng R et al. The impact of obesity and insulin resistance on outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod 2001; 16:1086-1091.

  11. Grimbizis GF, Camus M, Tarlatzis BC, et al. Clinical Implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update. 2007; 7:161-174.

  12. Grow DR, Iromloo K. Oral contraceptives maintain a very thin endometrium before operative hysteroscopy. Fertil Steril 2006; 85:204-207.

  13. Harlap S, Shiono PH: Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet 1980; 2: 173

  14. Heinonen PK. Reproductive performance of women with uterine anomalies after abdominal or hysteroscopic metroplasty or no surgical treatment. J Am Asoc Gynecol Laparosc 1997; 4:311-7.

  15. Holly B Ford, MD, Danny J Schust, MD, Recurrent Pregnancy Loss: Etiology, Diagnosis, and Therapy, Rev Obstet Gynecol. 2009; 2 (2): 76–83.

  16. Jacobs PA, Hassold T. Chromosome abnormalities: origin and etiology in abortions and live births. In: Vogel F; Sperling K eds. Human Genetics. Berlin: Springer-Verlag; 1987; 233-244

  17. Katz VL. Spontaneous and recurrent abortion: etiology, diagnosis, treatment. En: Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 5th ed. Philadelphia, Pa: Mosby Elsevier; 2007:16.

  18. Kline J, Stein ZA, Susser M et al: Smoking: A risk factor for spontaneous abortion. N Engl J Med 1977; 297:793.

  19. K. Kleinhaus, M. Perrin, Y. Friedlander, O Paltiel, D Malaspina, S Harlap, Paternal Age and Spontaneous Abortion, Rev. Obstetrics & Gynecology 2006 Agosto; vol. 108, n.2 : 369–377.

  20. Kovalevsky G, Gracia CR, Berlin JA, et al. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. Arch Int Med 2004; 164:558.

  21. Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engll J med 1997; 337:148-153.

  22. Leigh S. Joe, R.M. Eric, Pregnancy Loss. En: G. Gabbe Stevens, R. Niebyl Jennifer, Leigh S. Joe. Obstetrics: normal and problem pregnancies, 5th ed. Philadelphia, Pa: Churchill Livingstone/Elsevier, 2007: 24.

  23. Lim KJ, Odukoya OA, Ajjan RA, Li TC, Weeyman AP, Cooke ID .The role of T-helper cytokines in human reproduction. Fertil Steril 2000,73:136-142.

  24. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002; 99(2):333-41.

  25. Manzur Y. Alejandro, Aborto recurrente, Rev. Médica Clínica La Condes 2010; 21 (3): 416-423.

  26. Moffet A, Regan L, Braude P.Natural killer cells, miscarriage, and infertility. BMJ 2004; 329:1283-1285.

  27. Orhan Bukulmez, Aydin Arici, Luteal phase defect: myth or reality, Rev Obstetrics and Gynecology Clinics of North America 2004; 31(4): 727 – 744

  28. Oliveri MA, Henrique BC, Navarrete VJ, Caballero EA y col. Resección histeroscópica del septo uterino en mujeres infértiles. Rev Chil Obstet Ginecol 2005; 70(5):318-322.

  29. Pacheco, José et al, María Isabel de Michelena, Patricia Orihuela, Enfoque actual del aborto recurrente, rev. An. Fac. med. Lima jun. 2009; 70(2) 123-134

  30. Pattison NS, Chamley LW, McKay EJ, et al: Anthiphospholipid antibodies in pregnancy: Prevalence and clinical associations. Br J Obstet Gyneacol 1993;100:909.

  31. Perricone R, De Carolis C, Giacomelli R, Guarino MD, De Sanctis G, Fontana L.GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. Am J Reprod Immunol 2003; 50:232-237.

  32. Porter TF, La Coursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006; 2:CD000112.

  33. Raga F, Bauset C, Remohi J, et al. Reproductive impact of congenital Müllerian abnormalities. Hum Reprod. 1997; 12:2277-2281

  34. Rai R, Cohen H, Dave M, et al: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314:253.

  35. Rasch V. Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion. Acta Obstet Gynecol Scand. 2003; 82:182-188.

  36. Rubio C, Simon C, Vidal F, Rodrigo L, Pehlivan T, Remohi J, Pellicer A. Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Hum Reprod 2003; 18:182-188.

  37. Ruiz-Irastorza G, Khamashta MA, Nelson-Piercy C, et al. Lupus pregnancy: is heparin a risk factor for osteoporosis? Lupus 2001; 10:597-600

  38. Sanders B. Uterine factors and infertility. J Reprod Med 2006; 51(3):169-176.

  39. Savitz Da, Sonnenfeld NL, Olshan AF: Review of epidemiologic studies of paternal occupational exposure and spontaneous abortion. Am J Ind Med 1994;25:361.

  40. Scott JR, Rote NS, Branch DW: Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 1987; 70:645.

  41. Silver RK, MacGregor SN, Sholl JS, et al: Comparative trial of prednisone plus aspirin versus aspirin alone in treatment of anticardiolipina antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169:1411.

  42. Stomatellos I, Apostolides A, Stamatopoulos P, Bontis J. Pregnancy rates after hysteroscopic polipectomy depending on the size or number of the polyps. Arch Gynecol Obstet 2008; 227(5):395-399

  43. Venners SA, Wang X, Chen C et al. Paternal smoking and pregnancy loss: a prospective study using a biomarker of pregnancy. Am J Epidemiol 2004; 159:993-1001.

  44. Yamada H, Atsumi T, Kato EH, Shimada S, Morikawa M, Minakami H. Prevalence of diverse antiphospholipid antibodies in women with recurrent spontaneous abortion. Fem Steril 2003; 80:1276-1278.




2020     |     www.medigraphic.com